Navigation Links
Studying Fluid Overflow in Patients With Devices
Date:9/19/2011

uisen. "This study, among others, is aimed at finding the best ways to identify problems early, and monitoring patients remotely seems to be the best option. The question becomes which method we should use to monitor patients."

For a complete list of annual meeting sessions or for details on attending the conference, call (617) 226-7183 or visit www.hfsa.org and click on Annual Scientific Meeting. There is no registration fee for accredited journalists. Interview areas will be available on-site in addition to a fully-staffed press room with phone and internet accessibility. You may follow news from the meeting on Twitter #HFSA.

About Heart Failure

Heart failure is a progressive condition in which the heart muscle becomes weakened after it is injured, most commonly from heart attack or high blood pressure, and gradually loses its ability to pump enough blood to supply the body's needs. Many people are not aware they have heart failure because the symptoms are often mistaken for signs of getting older. Heart failure affects 4.6 to 4.8 million individuals in the United States. Demographic and clinical evidence strongly suggests that the prevalence of heart failure will increase throughout the next decade. Ten to 15 years ago heart failure was considered a "death sentence;" however, recent advances in treatment have shown that early diagnosis and proper care in early stages of the condition are key to slowing, stopping or in some cases reversing progression, improving quality of life, and extending life expectancy. For more information on heart failure, please visit www.abouthf.org.

About the Heart Failure Society of America

The Heart Failure Society of America (HFSA) is a nonprofit educational organization, founded in 1994 as the first organized association of heart failure experts. The HFSA provides a forum for all those intere
'/>"/>

SOURCE The Heart Failure Society of America
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV
2. Americas Biopharmaceutical Companies Studying 183 New Medicines to Counter Diabetes Growth
3. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
4. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
5. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
6. Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
7. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
8. EMIT Corporation Receives FDA 510(k) Clearance for HypothermX™ Blood and Fluid Warmer.
9. BioDrain Medical, Inc. Completes Installation of Its Streamway™ Automated Surgical Fluid Disposal System in Minnesota Hospital
10. Announcing 510(k) Clearance of a New Microfluidic-based IVD Test System, the uTASWako® i30 Immunoanalyzer, and AFP-L3 and DCP Assays for Liver Cancer Risk Assessment.
11. New Published Study Finds Noninvasive Masimo PVI Accurately Predicts Fluid Responsiveness in Intensive Care Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)...  Haemonetics Corporation (NYSE: HAE ) ... of its previously announced manufacturing transformation.  ... , Haemonetics has selected Sanmina Corporation (NASDAQ: ... medical devices currently manufactured in Braintree ... of integrated manufacturing solutions, components, products and repair, ...
(Date:6/19/2013)... Dr. Davis Lee , CMIO for PIH Health ... 2013 AMDIS Award, a prestigious recognition saluting excellence and ... "On behalf of Allscripts, I,d like to congratulate Dr. ... efforts to improve patient care and population health," said ... Officer of Allscripts. "We are committed to our partnership ...
(Date:6/19/2013)... , June 19, 2013 The American Association ... from Maryland , announced today the filing ... Washington, D.C. , asking that the scheduled ... for durable medical equipment (DME) be stopped because of serious ... Health and Human Services (HHS) Secretary Kathleen Sebelius ...
Breaking Medicine Technology:Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 2Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 5AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5
... After Ozarelix Was Maintained For ... Up To Six Months, ... Thereafter, IRVINE, Calif., Sept. 5 Spectrum,Pharmaceuticals, Inc., (Nasdaq: SPPI ... Company,s drug candidate for the,treatment of benign prostatic hypertrophy (BPH), at the ...
... Hosts Key Investigator Meeting for European Participants in ... 3 AGENDA Trial Targeting Biomarker-Defined Population, ... (Nasdaq: GNTA ) announced that data from ... plus chemotherapy would be,presented at the opening session ...
Cached Medicine Technology:Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 2Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 3Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 4Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 5Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 2Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 3Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 4Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 5
(Date:6/19/2013)... June 19, 2013 According to ... clinics, excessive sun exposure is perhaps the biggest ... cancer, but that is just one of many ... of skin cancer. Other risk factors include:, ...     Radiation treatment ,     Heredity may play a ...
(Date:6/19/2013)... 19, 2013 Across the globe billions ... no access to the medical advances that benefit developed ... to health care and the necessary aid to help ... , Outlook with Ben Kingsley is ... conditions in which these people live and highlight the ...
(Date:6/19/2013)... June 19, 2013 Are you using Twitter ... clients to the competition. , Social media marketing is ... massage practice. , Included in your social media campaigns ... tool in building awareness and revenue for your business. ... million Twitter users worldwide. Many of these individuals are not ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Harris ... located at The Wailea Town Center providing vacation rental ... brokerage. Ken Harris, a licensed Hawaii Realtor since ... and is the principal broker. , Harris Hawaii ... the Wailea resort area offers spectacular scenery, pristine beaches, ...
(Date:6/19/2013)... PrettySkin4Less announces it is stocking up with ... top skin care manufacturer EMINENCE to meet customer demands. ... and active organic ingredients to promote actual change rather ... products offer. For this reason it’s not hard to ... like products that do what they say they will ...
Breaking Medicine News(10 mins):Health News:Risk Factors of Skin Cancer & Reducing That Risk 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 3Health News:If Your Massage Practice Isn’t Tweeting, It Isn’t Generating New Sales: 3 Ways Twitter Helps Grow Massage Practices from Appointment-Plus 2Health News:Harris Hawaii Realtor Group Opens New Office in Wailea, HI 2Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2
... been,straightening teeth for decades relying on the ancient ... tooth displacement in one part of,the jaw causes ... dental implants as,orthodontic anchors, however, is changing that ... previously untreatable,cases, according to research presented at the ...
... PhD,. Associate Professor Xiao Cheng Wu, MD, PhD and ... Health Sciences Center New Orleans School of Public Health ... of the burden of human papillomavirus (HPV)-associated cancers in ... the Burden of Human Papillomavirus (HPV)-Associated Cancers in the ...
... Nov. 12 Nat,l Philanthropy Day Celebration Honors City,s Exemplary Orgs., ... ... The American Red Cross of Greater,Los Angeles will be honored as ... Nov. 12, 12:00,p.m., at the Beverly Hilton Hotel., This award is ...
... present promising results from dose-ranging study of new,oral anti-coagulant ... III trial slated to begin in December., NEW ... a new oral anti-clotting agent -- rivaroxaban -- designed ... subsequent Phase III efficacy,and safety trials. The results of ...
... highlights:, - A major long-term study of more ... vitamins taken by much of,the American population., - ... against heart,and blood vessel disease., NEW ORLEANS, Nov. ... by many American adults -- don,t protect,against cardiovascular disease ...
... A blood test recently approved for use in Europe ... used in the,United States., - The new blood ... should allow healthcare providers to focus attention,appropriately, both in ... A new blood test,identifies the sickest heart failure ...
Cached Medicine News:Health News:Dental Implants Effective for Orthodontic Treatment 2Health News:LSUHSC public health contributes to estimate of HPV-related cancers 2Health News:LSUHSC public health contributes to estimate of HPV-related cancers 3Health News:LSUHSC public health contributes to estimate of HPV-related cancers 4Health News:American Red Cross of Greater Los Angeles Named Outstanding Volunteer Organization 2Health News:Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data 2Health News:Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data 3Health News:Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data 4Health News:Two Antioxidant Vitamins Don't Protect Against Heart Disease 2Health News:Two Antioxidant Vitamins Don't Protect Against Heart Disease 3Health News:New Blood Test Better Identifies Heart Failure Patients in ER 2Health News:New Blood Test Better Identifies Heart Failure Patients in ER 3Health News:New Blood Test Better Identifies Heart Failure Patients in ER 4
... is an FDA approved rapid ... blood test used to aid ... infection. This CLIA waived test, ... antibodies to HIV-1, requires only ...
... The Acceava Mononucleosis test provides ... Mononucleosis with a simple procedure that ... Side-by-side evaluations with competitive products will ... These attributes enable you to deliver ...
Unitary one step immuno-chromatographic assay for the qualitative detection of infectious mononucleosis heterophile antibodies in human serum, plasma or whole blood....
... Influenza A+B test allows for the ... A and type B antigens directly ... nasal aspirate specimens. The test is ... rapid differential diagnosis of acute influenza ...
Medicine Products: